Clinical significance of bone metastasis with extraosseous soft-tissue mass in prostate cancer patients
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000030633
- Lead Sponsor
- Gifu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 720
Inclusion Criteria
Not provided
Exclusion Criteria
Patients without bone metastasis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method age, T/N stage, organ metastases, Gleason sum score, initial clinical symptoms, treatment methods, sites of PCBMs, initial PSA level (ng/mL), PSA nadir (ng/mL), PSA reduction rate (%), time from the initiation of therapy to PSA nadir (day), PSA doubling time (day), PSA progression-free survival (day), and overall survival (day)
- Secondary Outcome Measures
Name Time Method